Global Liver Institute leads European Liver Patients Association and Liver Patients International in letter to FDA/EMA demanding patient involvement in regulatory approval

The European Liver Patients Association and Liver Patients International joined the Global Liver Institute calling for patient involvement in the FDA and EMA regulatory process. 

It is critical that patients are heard and valued at federal agencies. The patient community is anxious to add our voice to the record and was dismayed to not be considered in recent FDA actions. 

See the letter sent to the FDA/EMA